Aileron Therapeutics At A Glance
This article was originally published in The Pink Sheet Daily
Business focus: novel stapled peptide drugs: peptide stapling technology stabilizes synthetic peptide
You may also be interested in...
Two-year old firm is developing novel peptide stapling technologies; potential initial therapeutic targets include hematological cancers.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.